DYAI 1.16 (-7.2%)
US26745T1016BiotechnologyBiotechnology

Dyadic (DYAI) Stock Highlights

1.16 | -7.2%
2024-09-19 06:45:04
Dyadic International Inc is a global biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Statistics

Range Today
1.16 1.25
Volume Today 39.5K
Range 1 Year
1.13 2.67
Volume 1 Year 11.67M
Range 3 Year
1.12 5.9
Volume 3 Year 41.11M
Range 10 Year
0.8 10.98
Volume 10 Year 483.71M

Highlights

Market Capitalization 36.55M (micro)
Floating Shares 18.98M
Current Price 1.16
Price To Earnings -4.63
Price To Revenue 17.75
Price To Book 11.59
Earnings Per Share -0.27
Payout Ratio 0%

Performance

Latest -7.2%
1 Month -13.43%
3 Months -40.82%
6 Months -21.62%
1 Year -34.46%
3 Years -77.99%
5 Years -81.14%
10 Years -30.12%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.